Cover Image
市場調查報告書

中國的PTCA球囊導管市場 (2015-2019年)

PTCA Balloon Catheter Market in China 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 336540
出版日期 內容資訊 英文 106 Pages
訂單完成後即時交付
價格
Back to Top
中國的PTCA球囊導管市場 (2015-2019年) PTCA Balloon Catheter Market in China 2015-2019
出版日期: 2015年07月29日 內容資訊: 英文 106 Pages
簡介

PTCA,是消除血液流向心肌時受阻的冠狀動脈的障礙物所使用的微創手術。這個手術中,為了除去斑塊造成的動脈閉塞壓迫,擴大堵塞的冠狀動脈,而設置PTCA球囊導管。PTCA球囊導管,是具備尖端可擴張球囊的軟式設備,在導管治療時插入動脈。並且讓球囊鼓起除去閉塞,擴大動脈。PTCA球囊導管,在介入性心臟病的領域中是最初使用的設備之一。Technavio的分析師預測中國的PTCA球囊導管市場從2014年到2019年以年複合成長率 (CAGR) 14.75%成長。

本報告以中國的PTCA球囊導管市場為主題,提供市場概要、市場發展推動因素、市場課題和那些的影響、各產品類型的市場現況與展望相關調查分析、主要的供應商分析彙整。

第1章 摘要整理

第2章 簡稱集

第3章 調查範圍

  • 市場概要
  • 提供產品

第4章 市場調查手法

  • 市場調查的過程
  • 調查手法

第5章 簡介

第6章 PTCA:概要

  • 關於PTCA
    • 背景
    • 定義
    • PTCA相關的次序
    • PTCA的優點
    • PTCA相關併發症和風險
    • PTCA球囊導管患病者
  • PTCA球囊導管的材料
    • 導管材料比較
  • 導管法的併發症
    • 背景
    • 併發症的原因

第7章 市場形勢

  • 市場概要
  • 市場規模、預測
  • 波特的五力分析

第8章 市場區隔,各產品類型

  • 一般球囊導管
  • 藥物釋放型球囊導管
  • 切割球囊導管
  • 折疊球囊導管

第9章 中國的醫療改革

  • 醫療改革
    • 取用醫療的保險的涵蓋範圍
    • 醫療基礎設施的改善

第10章 國際供應商及現場供應商的市場機會

  • 現場供應商
    • 現場供應商的課題
  • 國際供應商
    • 國際供應商的課題

第11章 購買條件

第12章 推動市場成長要素

第13章 推動因素與其影響

第14章 市場上課題

第15章 推動因素與課題的影響

第16章 市場趨勢

第17章 趨勢與其影響

第18章 業者情勢

  • 競爭模式
    • 主要消息
    • 吸收、合併
  • 市場佔有率分析,2014年
    • Abbott Laboratories
    • Boston Scientific
    • Medtronic
    • MicroPort Scientific
    • Terumo Corporation
  • 其他主要供應商

第19章 主要供應商分析 (主要的資訊、營業內容說明、主要產品、產業區分、產業策略、各產業分類銷售額、各區域銷售額、最近的趨勢、SWOT分析)

  • Abbott Laboratories
  • Boston Scientific
  • Medtronic
  • MicroPort Scientific
  • Terumo Corporation

第20章 本系列的其他報告

圖表清單

目錄
Product Code: IRTNTR6811

About PTCA balloon catheter

PTCA is a minimally invasive procedure used to remove the blockage of coronary arteries, permitting uninterrupted blood flow to the heart muscle. The procedure involves the placement of a PTCA balloon catheter to compress and clear the blockage caused by plaques and to widen the clogged coronary artery. A PTCA balloon catheter is a soft device equipped with a small inflatable balloon at its tip, which is inserted into an artery during the catheterization procedure. The balloon is then bloated to clear the blockage and widen the artery. PTCA balloon catheter was the first of its kind used in the field of interventional cardiology. It is also used to position stents during angioplasty.

Technavio's analysts forecast the PTCA balloon catheter market in China to grow at a CAGR of 14.75% over the period 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the PTCA balloon catheter market in China for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of PTCA balloon catheters.

Technavio's report, PTCA Balloon Catheter Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Boston Scientific
  • Medtronic
  • MicroPort Scientific
  • Terumo

Other Prominent Vendors

  • Aachen Resonance
  • Acrostak
  • AngioScore
  • Alvimedica
  • Asahi Intecc
  • Arthesys
  • Atrium Medical
  • B. Braun Melsungen
  • Biosensors International
  • BIOTRONIK
  • Cordis
  • Cook Medical
  • C.R. Bard
  • Goodman
  • Lepu Medical
  • Natec Medical
  • Smiths Medical
  • Tokai Medical Products
  • Volcano

Market driver

  • Growing geriatric population
  • For a full, detailed list, view our report

Market challenge

  • Alternative therapies
  • For a full, detailed list, view our report

Market trend

  • High demand for minimally invasive procedures
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. PTCA: An Overview

  • 06.1. About PTCA
    • 06.1.1. Background
    • 06.1.2. Definition
    • 06.1.3. Steps Involved in PTCA
    • 06.1.4. Advantages of PTCA
    • 06.1.5. Complications and Risks Involved in PTCA
    • 06.1.6. PTCA Balloon Catheters Affected Individuals
  • 06.2. PTCA Balloon Catheter Materials
    • 06.2.1. Comparison of Catheter Materials
  • 06.3. Complications of Catheterization
    • 06.3.1. Background
    • 06.3.2. Causes of Complications

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by Product Type

  • 08.1. Normal Balloon Catheter
  • 08.2. Drug-Eluting Balloon Catheter
  • 08.3. Cutting Balloon Catheter
  • 08.4. Scoring Balloon Catheter

09. Healthcare Reform in China

  • 09.1. Healthcare Reforms
    • 09.1.1. Insurance Coverage for Healthcare Access
    • 09.1.2. Improvement in Healthcare Infrastructure

10. Opportunities for Global and Local Vendors

  • 10.1. Local Vendors
    • 10.1.1. Challenges for Local Vendors
  • 10.2. Global Vendors
    • 10.2.1. Challenges for Global Vendors

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and Their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and Their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Market Share Analysis 2014
    • 18.2.1. Abbott Laboratories
    • 18.2.2. Boston Scientific
    • 18.2.3. Medtronic
    • 18.2.4. MicroPort Scientific
    • 18.2.5. Terumo
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Abbott Laboratories
    • 19.1.1. Key Facts
    • 19.1.2. Business Description
    • 19.1.3. Business Segmentation
    • 19.1.4. Business Strategy
    • 19.1.5. Revenue by Business Segmentation
    • 19.1.6. Revenue Comparison 2011 and 2012
    • 19.1.7. Revenue by Geographical Segmentation
    • 19.1.8. Key Information
    • 19.1.9. SWOT Analysis
  • 19.2. Boston Scientific
    • 19.2.1. Key Facts
    • 19.2.2. Business Overview
    • 19.2.3. Key Products
    • 19.2.4. Key Products in Cardiovascular Segment
    • 19.2.5. Key Products in MedSurg Segment
    • 19.2.6. Key Products in Rhythm Management Segment
    • 19.2.7. Business Segmentation by Revenue 2013
    • 19.2.8. Business Segmentation by Revenue 2012 and 2013
    • 19.2.9. Geographical Segmentation by Revenue 2013
    • 19.2.10. Business Strategy
    • 19.2.11. Recent Developments
    • 19.2.12. SWOT Analysis
  • 19.3. Medtronic
    • 19.3.1. Key Facts
    • 19.3.2. Business Overview
    • 19.3.3. Key Products
    • 19.3.4. Business Segmentation by Revenue 2014
    • 19.3.5. Cardiac and Vascular Group Segmentation by Revenue 2014
    • 19.3.6. Restorative Therapies Group Segmentation by Revenue 2014
    • 19.3.7. Diabetes Group Segmentation by Revenue 2014
    • 19.3.8. Business Segmentation by Revenue 2013 and 2014
    • 19.3.9. Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
    • 19.3.10. Restorative Therapies Group Segmentation by Revenue 2013 and 2014
    • 19.3.11. Diabetes Group Segmentation by Revenue 2013 and 2014
    • 19.3.12. Geographical Segmentation by Revenue 2014
    • 19.3.13. Business Strategy
    • 19.3.14. Key Developments
    • 19.3.15. SWOT Analysis
  • 19.4. MicroPort Scientific
    • 19.4.1. Key Facts
    • 19.4.2. Business Overview
    • 19.4.3. Business Segmentation by Revenue 2013
    • 19.4.4. Business Segmentation by Revenue 2012 and 2013
    • 19.4.5. Geographical Segmentation by Revenue 2013
    • 19.4.6. Business Strategy
    • 19.4.7. Recent Developments
    • 19.4.8. SWOT Analysis
  • 19.5. Terumo
    • 19.5.1. Key Facts
    • 19.5.2. Business Overview
    • 19.5.3. Business Segmentation
    • 19.5.4. Revenue Segmentation by Business
    • 19.5.5. Business Segment Revenue Comparison - FY2011 and FY2012
    • 19.5.6. Revenue Segmentation by Geography
    • 19.5.7. Business Strategy
    • 19.5.8. Key Developments
    • 19.5.9. SWOT Analysis

20. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Various Steps of PTCA
  • Exhibit 3: PTCA Balloon Catheter Materials
  • Exhibit 4: Common HAIs in Acute Care Settings
  • Exhibit 5: Major PTCA Balloon Catheter Complications
  • Exhibit 2: PTCA Balloon Catheter Market in China 2014-2019 ($ millions)
  • Exhibit 6: Segmentation of PTCA Balloon Catheter Market in China by Product Type
  • Exhibit 7: Segmentation of PTCA Balloon Catheter Market in China by Product Type 2014
  • Exhibit 8: Disease Mortality in China 2012
  • Exhibit 9: Healthcare Reforms in China
  • Exhibit 10: Number of Medical Institutes in China until 2012
  • Exhibit 11: Various Establishments of Top Global Medical Device Companies in China
  • Exhibit 12: Elderly Population in China 1950-2050
  • Exhibit 13: Healthcare Expenditure in China 2005-2014
  • Exhibit 14: Abbott Laboratories: Key Takeaways
  • Exhibit 15: Boston Scientific: Key Takeaways
  • Exhibit 16: Medtronic: Key Takeaways
  • Exhibit 17: MicroPort Scientific: Key Takeaways
  • Exhibit 18: Terumo: Key Takeaways
  • Exhibit 19: Abbott Laboratories: Business Segmentation
  • Exhibit 20: Abbott Laboratories: Revenue by Business Segmentation 2012
  • Exhibit 21: Abbott Laboratories: Revenue by Business Segmentation 2011 and 2012 ($ millions)
  • Exhibit 22: Abbott Laboratories: Revenue by Geographical Segmentation 2012
  • Exhibit 23: Boston Scientific: Key Products in Cardiovascular Segment
  • Exhibit 24: Boston Scientific: Key Products in MedSurg Segment
  • Exhibit 25: Boston Scientific: Key Products in Rhythm Management Segment
  • Exhibit 26: Boston Scientific: Business Segmentation by Revenue 2013
  • Exhibit 27: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ millions)
  • Exhibit 28: Boston Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 29: Medtronic: Key Products
  • Exhibit 30: Medtronic: Business Segmentation by Revenue 2014
  • Exhibit 31: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
  • Exhibit 32: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
  • Exhibit 33: Medtronic: Diabetes Group Segmentation by Revenue 2014
  • Exhibit 34: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 35: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 36: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 37: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 38: Medtronic: Geographical Segmentation by Revenue 2014
  • Exhibit 39: MicroPort Scientific: Business Segmentation by Revenue 2013
  • Exhibit 40: MicroPort Scientific: Business Segmentation by Revenue 2012 and 2013 ($ millions)
  • Exhibit 41: MicroPort Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 42: Business Segmentation of Terumo
  • Exhibit 43: Revenue Segmentation of Terumo
  • Exhibit 44: Revenue Comparison of Business Segments ($ billions)
  • Exhibit 45: Revenue Segmentation by Geography FY2012
Back to Top